文献速递治疗药物监测与药物基因组学特殊人群用药药物不良反应与药物警戒

儿科抗菌药物治疗药物监测的单中心回顾性研究

Therapeutic drug monitoring of antimicrobials in a paediatric setting: A retrospective single-centre study.
PubMed 文献 · Br J Clin Pharmacol · 2026-04-15

本研究回顾性分析了2021至2022年间某医院90例住院(83例患儿)的427次抗菌药物血清浓度检测,评估儿科TDM使用情况。结果显示22.0%的检测超过毒性阈值,万古霉素最常被监测;专家分类法显示50%未在范围内。TDM在复杂儿科患者中可能有助于个体化抗菌药物剂量调整。

要点

  • 儿科抗菌药物TDM中22.0%的检测超过毒性阈值,万古霉素最常监测。
  • 专家分类法显示50%未在治疗范围内,26.7%在范围内,23.3%不确定。
  • TDM可能有助于复杂儿科患者的抗菌药物个体化给药。

核心结论

  • TDM频繁发现超出范围的血清药物浓度,约五分之一住院期间观察到潜在毒性水平。
  • 在复杂儿科患者中,TDM可能是抗菌药物个体化剂量的有用工具。

研究设计与样本

  • 回顾性单中心研究,纳入2021至2022年住院的<18岁儿科患者,共90次住院(83例患者)的427次抗菌药物血清浓度检测。
  • 主要目标为描述TDM利用情况,即维持治疗性血清浓度的患者比例;次要目标包括临床结局及与超出范围浓度相关的因素。
  • 采用两种TDM分类:基于毒性阈值的二分类法和专家分类法。

主要发现

  • 患者中位年龄0.2岁,41.1%为女性;万古霉素是最常监测的抗菌药物。
  • 总体22.0%的检测超过毒性阈值;基于二分类法,毒性组首次SDC检测时间显著更短,心血管和肾脏合并症发生率更高。
  • 专家分类法显示50%未在范围内,26.7%在范围内,23.3%不确定;在范围组患者肾衰竭、CRRT使用和死亡率更高(20.8% vs. 4.4%,p = .045),但敏感性分析中不显著。
  • Kaplan-Meier曲线显示无生存差异。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

AIMS: Paediatric pharmacokinetics differ significantly from adults due to age-related physiological changes, necessitating precise dose adjustments. However, data on therapeutic drug monitoring (TDM) implementation in paediatric setting remain limited. This study assessed TDM use at ASST Grande Ospedale Metropolitano Niguarda, where clinical pharmacologists support therapy optimization, especially in high-intensity care settings. METHODS: This retrospective study included paediatric patients (<18 years) admitted to our hospital who underwent serum drug concentration (SDC) testing for antimicrobials between 2021 and 2022. The primary objective was to describe TDM utilization, specifically the proportion of patients maintaining therapeutic SDC levels. Secondary objectives included clinical outcomes and factors linked to out-of-range SDC levels. Two TDM classifications, binary based on toxicity thresholds and expert-based, were used. RESULTS: Among 427 SDC tests from 90 hospital stays (83 patients), median patient age was 0.2 years, and 41.1% were female. Overall, 22.0% of tests exceeded toxicity thresholds; vancomycin was most frequently monitored. The toxic group, based on binary classification, had a significantly shorter time-to-first SDC and higher rates of cardiovascular and renal comorbidities compared with the non-toxic group. Expert-based classification showed 50% not-in-range, 26.7% in-range, and 23.3% indeterminate. In-range patients had higher renal failure, CRRT use, and mortality (20.8% vs. 4.4%, p = .045), though not significant in sensitivity analyses. Kaplan-Meier curves showed no survival difference. CONCLUSIONS: TDM frequently identified out-of-range SDC, with potentially toxic levels observed in approximately one fifth of hospital stays. In this context, TDM may represent a useful tool for individualized antimicrobial dosing in complex paediatric patients.

来源:Br J Clin Pharmacol,查看原文。版权归原作者所有。

引用

  1. Gazzaniga G, Agliardi S, Giossi R, et al. Therapeutic drug monitoring of antimicrobials in a paediatric setting: A retrospective single-centre study. Br J Clin Pharmacol. 2026. PMID: 41983522. doi:10.1002/bcp.70556

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。